Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Research Report 2024

List of Figures, Tables and Charts Available in Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Research Report 2024

List of Tables
Table 1. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) of Key Manufacturers (2019-2024)
Table 5. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Diphtheria, Tetanus, and Pertussis Combined Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diphtheria, Tetanus, and Pertussis Combined Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2019-2024) & (Million Doses)
Table 18. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2025-2030) & (Million Doses)
Table 20. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2024) & (Million Doses)
Table 27. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2025-2030) & (Million Doses)
Table 28. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2024) & (Million Doses)
Table 32. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2025-2030) & (Million Doses)
Table 33. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2019-2024) & (Million Doses)
Table 37. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Region (2025-2030) & (Million Doses)
Table 38. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2024) & (Million Doses)
Table 42. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2025-2030) & (Million Doses)
Table 43. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2019-2024) & (Million Doses)
Table 47. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales by Country (2025-2030) & (Million Doses)
Table 48. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) by Type (2019-2024)
Table 51. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) by Type (2025-2030)
Table 52. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Type (2019-2024)
Table 59. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Type (2025-2030)
Table 60. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) by Application (2019-2024)
Table 61. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses) by Application (2025-2030)
Table 62. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Application (2019-2024)
Table 69. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Application (2025-2030)
Table 70. Sanofi Pasteur Corporation Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Sanofi Pasteur Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. GSK Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 79. GSK Recent Developments/Updates
Table 80. Mitsubishi Tanabe Pharma Corporation Information
Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
Table 82. Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Mitsubishi Tanabe Pharma Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 85. KM Biologics Corporation Information
Table 86. KM Biologics Description and Business Overview
Table 87. KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. KM Biologics Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 89. KM Biologics Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Corporation Information
Table 91. Wuhan Institute of Biological Products Description and Business Overview
Table 92. Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Wuhan Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
Table 95. Walvax Biotechnology Corporation Information
Table 96. Walvax Biotechnology Description and Business Overview
Table 97. Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Walvax Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 99. Walvax Biotechnology Recent Developments/Updates
Table 100. Chengdu Institute of Biological Products Corporation Information
Table 101. Chengdu Institute of Biological Products Description and Business Overview
Table 102. Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. Chengdu Institute of Biological Products Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
Table 105. Minhai Biotechnology Corporation Information
Table 106. Minhai Biotechnology Description and Business Overview
Table 107. Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (Million Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Minhai Biotechnology Diphtheria, Tetanus, and Pertussis Combined Vaccine Product
Table 109. Minhai Biotechnology Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Diphtheria, Tetanus, and Pertussis Combined Vaccine Distributors List
Table 113. Diphtheria, Tetanus, and Pertussis Combined Vaccine Customers List
Table 114. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Trends
Table 115. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Drivers
Table 116. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Challenges
Table 117. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Diphtheria, Tetanus, and Pertussis Combined Vaccine
Figure 2. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Share by Type in 2023 & 2030
Figure 4. Inactivated Vaccine Product Picture
Figure 5. Other Product Picture
Figure 6. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Share by Application in 2023 & 2030
Figure 8. 12 Months Below
Figure 9. 12 Months Above
Figure 10. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size (2019-2030) & (US$ Million)
Figure 12. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales (2019-2030) & (Million Doses)
Figure 13. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Average Price (USD/Dose) & (2019-2030)
Figure 14. Diphtheria, Tetanus, and Pertussis Combined Vaccine Report Years Considered
Figure 15. Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Share by Manufacturers in 2023
Figure 16. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Diphtheria, Tetanus, and Pertussis Combined Vaccine Players: Market Share by Revenue in 2023
Figure 18. Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Country (2019-2030)
Figure 21. North America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Country (2019-2030)
Figure 22. United States Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Country (2019-2030)
Figure 25. Europe Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Country (2019-2030)
Figure 26. Germany Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Region (2019-2030)
Figure 33. China Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Country (2019-2030)
Figure 41. Latin America Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Sales Market Share by Country (2019-2030)
Figure 46. Middle East & Africa Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Market Share by Country (2019-2030)
Figure 47. Turkey Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Saudi Arabia Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. UAE Diphtheria, Tetanus, and Pertussis Combined Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Global Sales Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Type (2019-2030)
Figure 51. Global Revenue Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Type (2019-2030)
Figure 52. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Type (2019-2030)
Figure 53. Global Sales Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Application (2019-2030)
Figure 54. Global Revenue Market Share of Diphtheria, Tetanus, and Pertussis Combined Vaccine by Application (2019-2030)
Figure 55. Global Diphtheria, Tetanus, and Pertussis Combined Vaccine Price (USD/Dose) by Application (2019-2030)
Figure 56. Diphtheria, Tetanus, and Pertussis Combined Vaccine Value Chain
Figure 57. Diphtheria, Tetanus, and Pertussis Combined Vaccine Production Process
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Distributors Profiles
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed